Drug Type tRNA, AAV based gene therapy |
Synonyms- |
Target |
Mechanism COL4A5 modulators(collagen type IV alpha 5 chain modulators) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Nephritis, Hereditary | Preclinical | CN | 07 May 2024 |